A detailed history of Hrt Financial LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 47,986 shares of ATRC stock, worth $2.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
47,986
Previous 29,294 63.81%
Holding current value
$2.03 Million
Previous $667,000 101.65%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$20.34 - $29.5 $380,195 - $551,414
18,692 Added 63.81%
47,986 $1.35 Million
Q2 2024

Aug 12, 2024

SELL
$19.86 - $29.09 $136,815 - $200,401
-6,889 Reduced 19.04%
29,294 $667,000
Q1 2024

May 13, 2024

BUY
$28.21 - $37.78 $291,296 - $390,116
10,326 Added 39.94%
36,183 $1.1 Million
Q4 2023

Feb 09, 2024

BUY
$32.99 - $43.25 $853,022 - $1.12 Million
25,857 New
25,857 $922,000
Q1 2023

May 12, 2023

BUY
$35.87 - $47.22 $2.54 Million - $3.34 Million
70,813 Added 886.6%
78,800 $3.27 Million
Q4 2022

Feb 10, 2023

BUY
$33.48 - $47.45 $267,404 - $378,983
7,987 New
7,987 $354,000
Q1 2022

May 16, 2022

SELL
$57.43 - $71.39 $915,663 - $1.14 Million
-15,944 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$63.4 - $87.14 $16,103 - $22,133
-254 Reduced 1.57%
15,944 $1.11 Million
Q3 2021

Nov 15, 2021

BUY
$69.28 - $84.46 $1.12 Million - $1.37 Million
16,198 New
16,198 $1.13 Million
Q1 2021

May 17, 2021

SELL
$53.79 - $66.98 $299,664 - $373,145
-5,571 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$34.56 - $57.55 $79,384 - $132,192
-2,297 Reduced 29.19%
5,571 $310,000
Q3 2020

Nov 13, 2020

BUY
$38.36 - $46.91 $301,816 - $369,087
7,868 New
7,868 $313,000
Q2 2019

Aug 14, 2019

SELL
$26.85 - $30.74 $236,414 - $270,665
-8,805 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$26.38 - $33.34 $232,275 - $293,558
8,805 New
8,805 $235,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.97B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.